131 related articles for article (PubMed ID: 7934956)
1. Use of transgenic mouse lacI/Z mutation assays in genetic toxicology.
Ashby J; Tinwell H
Mutagenesis; 1994 May; 9(3):179-81. PubMed ID: 7934956
[TBL] [Abstract][Full Text] [Related]
2. A preliminary evaluation of the performance of the Muta Mouse (lacZ) and Big Blue (lacI) transgenic mouse mutation assays.
Morrison V; Ashby J
Mutagenesis; 1994 Jul; 9(4):367-75. PubMed ID: 7968580
[TBL] [Abstract][Full Text] [Related]
3. Response of the Muta mouse lacZ/galE- transgenic mutation assay to DMN: comparisons with the corresponding Big Blue (lacI) responses.
Tinwell H; Lefevre PA; Ashby J
Mutat Res; 1994 May; 307(1):169-73. PubMed ID: 7513794
[TBL] [Abstract][Full Text] [Related]
4. Comparison of lacI and lacZ transgenic mouse mutation assays: an EU-sponsored interlaboratory study.
Tinwell H; Liegibel U; Krebs O; Schmezer P; Favor J; Ashby J
Mutat Res; 1995 Oct; 335(2):185-90. PubMed ID: 7477049
[TBL] [Abstract][Full Text] [Related]
5. Initial experiences and future directions for transgenic mouse mutation assays.
Suzuki T; Hayashi M; Sofuni T
Mutat Res; 1994 Jun; 307(2):489-94. PubMed ID: 7514722
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific induction of mutations by streptozotocin in vivo.
Schmezer P; Eckert C; Liegibel UM
Mutat Res; 1994 Jun; 307(2):495-9. PubMed ID: 7514723
[TBL] [Abstract][Full Text] [Related]
7. The lacI transgenic mouse mutagenicity assay: quantitative evaluation in comparison to tests for carcinogenicity and cytogenetic damage in vivo.
Shephard SE; Lutz WK; Schlatter C
Mutat Res; 1994 Apr; 306(2):119-28. PubMed ID: 7512210
[TBL] [Abstract][Full Text] [Related]
8. Use of transgenic mutational test systems in risk assessment of carcinogens.
Schmezer P; Eckert C; Liegibel UM; Klein RG; Bartsch H
Arch Toxicol Suppl; 1998; 20():321-30. PubMed ID: 9442305
[TBL] [Abstract][Full Text] [Related]
9. Measurement of gene mutation in vivo using Muta Mouse and positive selection for lacZ- phage.
Dean SW; Myhr B
Mutagenesis; 1994 May; 9(3):183-5. PubMed ID: 7934957
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the genetic toxicity of the peroxisome proliferator and carcinogen methyl clofenapate, including assays using Muta Mouse and Big Blue transgenic mice.
Lefevre PA; Tinwell H; Galloway SM; Hill R; Mackay JM; Elcombe CR; Foster J; Randall V; Callander RD; Ashby J
Hum Exp Toxicol; 1994 Nov; 13(11):764-75. PubMed ID: 7857696
[TBL] [Abstract][Full Text] [Related]
11. The use of shuttle vectors for mutation analysis in transgenic mice and rats.
Dycaico MJ; Provost GS; Kretz PL; Ransom SL; Moores JC; Short JM
Mutat Res; 1994 Jun; 307(2):461-78. PubMed ID: 7514720
[TBL] [Abstract][Full Text] [Related]
12. Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea.
Allay E; Veigl M; Gerson SL
Oncogene; 1999 Jun; 18(25):3783-7. PubMed ID: 10391687
[TBL] [Abstract][Full Text] [Related]
13. Transgenic mouse mutation assay systems can play an important role in regulatory mutagenicity testing in vivo for the detection of site-of-contact mutagens.
Dean SW; Brooks TM; Burlinson B; Mirsalis J; Myhr B; Recio L; Thybaud V
Mutagenesis; 1999 Jan; 14(1):141-51. PubMed ID: 10474836
[TBL] [Abstract][Full Text] [Related]
14. A strategy for the application of transgenic rodent mutagenesis assays.
Gorelick NJ; Mirsalis JC
Environ Mol Mutagen; 1996; 28(4):434-42. PubMed ID: 8991075
[TBL] [Abstract][Full Text] [Related]
15. Correlation of carcinogenic potency with mouse-skin 32P-postlabeling and muta-Rmouse lac Z- mutation data for DMBA and its K-region sulphur isostere: comparison with activities observed in standard genotoxicity assays.
Ashby J; Brusick D; Myhr BC; Jones NJ; Parry JM; Nesnow S; Paton D; Tinwell H; Rosenkranz HS; Curti S
Mutat Res; 1993 Aug; 292(1):25-40. PubMed ID: 7688094
[TBL] [Abstract][Full Text] [Related]
16. Mutagenic response to benzene and tris(2,3-dibromopropyl)-phosphate in the lambda lacI transgenic mouse mutation assay: a standardized approach to in vivo mutation analysis.
Provost GS; Mirsalis JC; Rogers BJ; Short JM
Environ Mol Mutagen; 1996; 28(4):342-7. PubMed ID: 8991062
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue transgenic mouse mutation assay.
Suter W; Ahiabor R; Blanco B; Locher F; Mantovani F; Robinson M; Sreenan G; Staedtler F; Swingler T; Vignutelli A; Perentes E
Environ Mol Mutagen; 1996; 28(4):354-62. PubMed ID: 8991064
[TBL] [Abstract][Full Text] [Related]
18. Reporter gene transgenic mice as a tool for analyzing the molecular mechanisms underlying experimental carcinogenesis.
Nishikawa A; Suzuki T; Masumura K; Furukawa F; Miyauchi M; Nakamura H; Son HY; Nohmi T; Hayashi M; Hirose M
J Exp Clin Cancer Res; 2001 Mar; 20(1):111-5. PubMed ID: 11370817
[TBL] [Abstract][Full Text] [Related]
19. In vivo mutagenesis by the hepatocarcinogen quinoline in the lacZ transgenic mouse: evidence for its in vivo genotoxicity.
Suzuki T; Miyata Y; Saeki K; Kawazoe Y; Hayashi M; Sofuni T
Mutat Res; 1998 Jan; 412(2):161-6. PubMed ID: 9539970
[TBL] [Abstract][Full Text] [Related]
20. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
